Call Us Toll Free: 1-800-388-9993

 

A reliable investment strategy: Identify a widely diversified portfolio of high-quality stocks and build up additional holdings at favorable prices.

 

DRIPs can help you do that.

 

Even small investors can follow such a strategy by investing through dividend reinvestment plans (DRIPs). That's because it takes ownership of only a single share of company stock to establish an account. Therefore, there is nothing to stop you from buying companies in a variety of industries.

 

As for buying at favorable prices, dollar-cost averaging virtually assures that you will buy most shares at favorable prices. And DRIPs provide an excellent way to dollar-cost average. These plans allow you to invest cash amounts to buy shares directly from the company. Once you are enrolled in a plan, you can invest amounts of as little as $25 or $50 (or as much as you can afford) to buy shares or fractions of shares. That's different than the traditional way to invest, which is to pay brokerage fees to buy a certain number of shares.

 

 

Novartis AG (NVS)

Available from the Temper Enrollment Service: Yes


Last Update On: 01/28/2020:

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company's Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, and established medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas and finished dosage form anti-infective. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics protein- or other biotechnology-based products, including biosimilars and biotechnology manufacturing services. The company's Alcon segment offers intraocular lenses and equipment for cataract procedures equipment, instruments, and devices for vitreoretinal surgeries surgical equipment and diagnostic devices for refractive surgical procedures and devices to treat glaucoma. It also provides viscoelastics, surgical solutions, diagnostic ophthalmic products, surgical packs, and other disposable products for cataract and vitreoretinal surgery. In addition, this segment offers contact lenses and ocular health products over-the-counter ophthalmic products eye drops for the temporary relief of ocular itching due to allergies vitamins for ocular health and iLux Device, a therapeutic device used to treat meibomian gland dysfunction. Novartis AG has collaboration agreements with Xencor Surface Oncology Ligand Pharmaceuticals, Inc. Amgen University of California, Berkeley Bristol-Myers Squibb IBM Watson Health Allergan plc Science 37, Inc. Bill & Melinda Gates Foundation PEAR Therapeutics Pfizer Conatus Pharmaceuticals Inc. TRIO and Verily. The company was founded in 1895 and is headquartered in Basel, Switzerland. **Taken from Yahoo Finance**

Industry: Healthcare Products
Minimum Investment: $50.00
Maximum Investment: $100,000/year
Shares to qualify: 1
Recent Price: 84.85
Investing Fee: $0!
Fee for Dividends: 0

! = Company pays fees

Information is based on an annual survey and updated when company changes become available.

Click for Español

FOR MORE
INFORMATION

And a free copy of The Moneypaper's direct investing brochure, please enter your contact information below.

You will also be signed up to receive our monthly stock special.

You can unsubscribe at any time. We do not share your email with anyone.

By email, you get the Monthly “Stock Special,” where the service fee for enrollment in a great DRIP stock is reduced.

* Required Field.